Literature DB >> 3377080

Effects of cholecystokinin octapeptide on contractile motility of guinea pig common bile duct.

T Takahashi1, M Kusunoki, M Kantoh, T Yamamura, J Utsunomiya.   

Abstract

Cholecystokinin octapeptide (CCK-8)-induced contraction and [3H]acetylcholine ([3H]-ACh) release from the longitudinal muscle strip of the guinea pig common bile duct were studied by a standard organ bath method and superfusion system. CCK-8 (10(-7) M) caused a biphasic contraction, a rapid phasic contraction followed by a fading tonic contraction. Hexamethonium, propranolol, and phentolamine had no effects on CCK-8-evoked contraction. Atropine or tetrodotoxin significantly reduced CCK-8-evoked initial phasic contraction and produced a rightward shift of the dose-response curve for CCK-8 (10(-10)-3 x 10(-7) M). CCK-8 provoked a significant [3H]ACh release in a dose-dependent manner, which was almost completely abolished by tetrodotoxin or Ca2+-free medium. These results suggest that CCK-8 receptors are present not only on the smooth muscle cells but also on the intramural cholinergic nerve cell bodies of the guinea pig common bile duct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377080     DOI: 10.1152/ajpgi.1988.254.6.G819

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Effects of a new cholecystokinin antagonist (GE 410) on the smooth muscle of the guinea pig ileum.

Authors:  A Rakovska; K Milenov; P Henklein
Journal:  Experientia       Date:  1990-10-15

2.  Human pancreatic polypeptide, neuropeptide Y and peptide YY reduce the contractile motility by depressing the release of acetylcholine from the myenteric plexus of the guinea pig ileum.

Authors:  T Takahashi; T Yamamura; J Utsunomiya
Journal:  Gastroenterol Jpn       Date:  1992-06

3.  Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus.

Authors:  K Nakamura; T Takahashi; M Taniuchi; C X Hsu; C Owyang
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.